Patients treated with a tumor necrosis factor-α inhibitor are more likely to develop extrapulmonary tuberculosis

Documenti analoghi

• Tumor necrosis factor-α inhibitor use in patients with malignancy: is it safe?
  di: Oh, Gyu Man, et al.
  Pubblicazione: (2020)
• Uveitis Reactivation in Children Treated with Tumor Necrosis Factor-α Inhibitors
  di: Lerman, Melissa A., et al.
  Pubblicazione: (2015)
• Senile/solar purpura like lesions developed in association with use of tumor necrosis factor-α (TNF-α) inhibitors
  di: Anca Chiriac, et al.
  Pubblicazione: (2014-01-01)
• Unusual location of tuberculosis in the course of tumor necrosis factor α inhibitor therapy
  di: Bielewicz-Zielińska, Agnieszka, et al.
  Pubblicazione: (2015)
• Clinical characteristics and treatment responses of patients who developed tuberculosis following use of a tumor necrosis factor-α inhibitor
  di: Chung, Keun Bum, et al.
  Pubblicazione: (2013)